BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23616104)

  • 1. Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole.
    Dixit S; Dubey R; Bhushan R
    Biomed Chromatogr; 2014 Jan; 28(1):112-9. PubMed ID: 23616104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimilligram enantioresolution of sulfoxide proton pump inhibitors by liquid chromatography on polysaccharide-based chiral stationary phase.
    Belaz KR; Coimbra M; Barreiro JC; Montanari CA; Cass QB
    J Pharm Biomed Anal; 2008 May; 47(1):81-7. PubMed ID: 18242919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversed-phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of their Acid-induced degradation products.
    El-Sherif ZA; Mohamed AO; El-Bardicy MG; El-Tarras MF
    Chem Pharm Bull (Tokyo); 2006 Jun; 54(6):814-8. PubMed ID: 16755049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparative chiral chromatography and chiroptical characterization of enantiomers of omeprazole and related benzimidazoles.
    Andersson S; Nelander H; Ohlén K
    Chirality; 2007 Sep; 19(9):706-15. PubMed ID: 17348004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral separation of lansoprazole and rabeprazole by capillary electrophoresis using dual cyclodextrin systems.
    Papp LA; Hancu G; Gyéresi Á; Kelemen H; Szabó ZI; Noszál B; Dubský P; Tóth G
    Electrophoresis; 2019 Nov; 40(21):2799-2805. PubMed ID: 31281995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective disposition of proton pump inhibitors.
    Andersson T; Weidolf L
    Clin Drug Investig; 2008; 28(5):263-79. PubMed ID: 18407713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the enantiomeric impurity in S-(-)pantoprazole using high performance liquid chromatography with sulfobutylether-beta-cyclodextrin as chiral additive.
    Guan J; Yang J; Bi Y; Shi S; Yan F; Li F
    J Sep Sci; 2008 Feb; 31(2):288-93. PubMed ID: 18196525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral resolution of pantoprazole sodium and related sulfoxides by complex formation with bovine serum albumin in capillary electrophoresis.
    Eberle D; Hummel RP; Kuhn R
    J Chromatogr A; 1997 Jan; 759(1-2):185-92. PubMed ID: 9050224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.
    Bharathi DV; Hotha KK; Jagadeesh B; Chatki PK; Thriveni K; Mullangi R; Naidu A
    Biomed Chromatogr; 2009 Jul; 23(7):732-9. PubMed ID: 19360758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioseparation of selected chiral sulfoxides in high-performance liquid chromatography with polysaccharide-based chiral selectors in polar organic mobile phases with emphasis on enantiomer elution order.
    Gegenava M; Chankvetadze L; Farkas T; Chankvetadze B
    J Sep Sci; 2014 May; 37(9-10):1083-8. PubMed ID: 24634398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct HPLC enantioseparation of omeprazole and its chiral impurities: application to the determination of enantiomeric purity of esomeprazole magnesium trihydrate.
    Zanitti L; Ferretti R; Gallinella B; La Torre F; Sanna ML; Mosca A; Cirilli R
    J Pharm Biomed Anal; 2010 Sep; 52(5):665-71. PubMed ID: 20338705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved HPLC method for determination of four PPIs, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma.
    Noubarani M; Keyhanfar F; Motevalian M; Mahmoudian M
    J Pharm Pharm Sci; 2010; 13(1):1-10. PubMed ID: 20456825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chiral bioconversion and preclinical pharmacokinetic analysis of (R)-(+)-rabeprazole in beagle dogs by HPLC and HPLC-MS/MS.
    Gao YH; Xu JX; Su ZX; Song L; Lou HX
    Biomed Chromatogr; 2013 Nov; 27(11):1380-6. PubMed ID: 23703236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel amylose and cellulose-based chiral stationary phases for the stereoisomer separation of flavanones by means of nano-liquid chromatography.
    Si-Ahmed K; Aturki Z; Chankvetadze B; Fanali S
    Anal Chim Acta; 2012 Aug; 738():85-94. PubMed ID: 22790704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatographic resolution of proton pump inhibitors including omeprazole on a ligand exchange chiral stationary phase.
    Ha JJ; Choi HJ; Jin JS; Jeong ED; Hyun MH
    J Chromatogr A; 2010 Oct; 1217(41):6436-41. PubMed ID: 20828702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.
    Miner P; Katz PO; Chen Y; Sostek M
    Am J Gastroenterol; 2003 Dec; 98(12):2616-20. PubMed ID: 14687806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous enantioselective determination of omeprazole, rabeprazole, lansoprazole, and pantoprazole enantiomers in human plasma by chiral liquid chromatography-tandem mass spectrometry.
    Sun LN; Zhang Y; Yang YQ; Shen Y; Ying YW; Su YW; Zhang XH; Liu Y; Huang X; Wang YQ
    J Sep Sci; 2020 Aug; 43(16):3183-3196. PubMed ID: 32495501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution and determination of enantiomeric purity of new chiral derivatives of xanthones using polysaccharide-based stationary phases.
    Fernandes C; Brandão P; Santos A; Tiritan ME; Afonso C; Cass QB; Pinto MM
    J Chromatogr A; 2012 Dec; 1269():143-53. PubMed ID: 22889602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction.
    Miura M; Tada H; Satoh S; Habuchi T; Suzuki T
    J Pharm Biomed Anal; 2006 May; 41(2):565-70. PubMed ID: 16442771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography.
    Ekpe A; Jacobsen T
    Drug Dev Ind Pharm; 1999 Sep; 25(9):1057-65. PubMed ID: 10518247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.